These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29744290)

  • 1. Identification of small-molecule elastase inhibitors as antagonists of IL-36 cytokine activation.
    Sullivan GP; Davidovich PB; Sura-Trueba S; Belotcerkovskaya E; Henry CM; Clancy DM; Zinoveva A; Mametnabiev T; Garabadzhiu AV; Martin SJ
    FEBS Open Bio; 2018 May; 8(5):751-763. PubMed ID: 29744290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases.
    Sullivan GP; Henry CM; Clancy DM; Mametnabiev T; Belotcerkovskaya E; Davidovich P; Sura-Trueba S; Garabadzhiu AV; Martin SJ
    Cell Death Dis; 2018 Mar; 9(3):378. PubMed ID: 29515113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines.
    Henry CM; Sullivan GP; Clancy DM; Afonina IS; Kulms D; Martin SJ
    Cell Rep; 2016 Feb; 14(4):708-722. PubMed ID: 26776523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of biologically active IL-36 family cytokines through insertion of N-terminal caspase cleavage motifs.
    Clancy DM; Henry CM; Davidovich PB; Sullivan GP; Belotcerkovskaya E; Martin SJ
    FEBS Open Bio; 2016 Apr; 6(4):338-48. PubMed ID: 27239446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis.
    Guo J; Tu J; Hu Y; Song G; Yin Z
    Drug Des Devel Ther; 2019; 13():581-588. PubMed ID: 30804664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis.
    Todorović V; Su Z; Putman CB; Kakavas SJ; Salte KM; McDonald HA; Wetter JB; Paulsboe SE; Sun Q; Gerstein CE; Medina L; Sielaff B; Sadhukhan R; Stockmann H; Richardson PL; Qiu W; Argiriadi MA; Henry RF; Herold JM; Shotwell JB; McGaraughty SP; Honore P; Gopalakrishnan SM; Sun CC; Scott VE
    Sci Rep; 2019 Jun; 9(1):9089. PubMed ID: 31235749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing.
    Clancy DM; Sullivan GP; Moran HBT; Henry CM; Reeves EP; McElvaney NG; Lavelle EC; Martin SJ
    Cell Rep; 2018 Mar; 22(11):2937-2950. PubMed ID: 29539422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist.
    Macleod T; Doble R; McGonagle D; Wasson CW; Alase A; Stacey M; Wittmann M
    Sci Rep; 2016 Apr; 6():24880. PubMed ID: 27101808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.
    Milora KA; Fu H; Dubaz O; Jensen LE
    J Invest Dermatol; 2015 Dec; 135(12):2992-3000. PubMed ID: 26203636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of IL-36 cytokines and their role in disease.
    Gresnigt MS; van de Veerdonk FL
    Semin Immunol; 2013 Dec; 25(6):458-65. PubMed ID: 24355486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis.
    Madonna S; Girolomoni G; Dinarello CA; Albanesi C
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated sputum IL-36 levels are associated with neutrophil-related inflammation in COPD patients.
    Li W; Meng X; Hao Y; Chen M; Jia Y; Gao P
    Clin Respir J; 2021 Jun; 15(6):648-656. PubMed ID: 33559376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases.
    Walsh PT; Fallon PG
    Ann N Y Acad Sci; 2018 Apr; 1417(1):23-34. PubMed ID: 27783881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development.
    Queen D; Ediriweera C; Liu L
    Front Cell Dev Biol; 2019; 7():317. PubMed ID: 31867327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
    Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
    J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ.
    Ainscough JS; Macleod T; McGonagle D; Brakefield R; Baron JM; Alase A; Wittmann M; Stacey M
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2748-E2757. PubMed ID: 28289191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1α and IL-36 Family Cytokines Can Undergo Processing and Activation by Diverse Allergen-Associated Proteases.
    Frezza V; Najda Z; Davidovich P; Sullivan GP; Martin SJ
    Front Immunol; 2022; 13():879029. PubMed ID: 35844537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.
    Bridgewood C; Fearnley GW; Berekmeri A; Laws P; Macleod T; Ponnambalam S; Stacey M; Graham A; Wittmann M
    Front Immunol; 2018; 9():200. PubMed ID: 29535706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin(IL)-36α and IL-36γ Induce Proinflammatory Mediators from Human Colonic Subepithelial Myofibroblasts.
    Kanda T; Nishida A; Takahashi K; Hidaka K; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Front Med (Lausanne); 2015; 2():69. PubMed ID: 26442271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.